Skip to main content

Table 1 Patient demographic and clinical characteristics at baseline according to gender (Phase 1)

From: Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment — a comparative study

Mean ± SD Women(173) Men(90) Overall(263)
Age (years) 83.1 ± 7.2 82.6 ± 6.9 82.9 ± 7.1
Weight (kg) 62.9 ± 11.6 73.9 ± 10.1 69.8 ± 12.2
Height (m) 1.5 ± 0.1 1.6 ± 0.1 1.6 ± 0.1
BMI (Kg/m2) 26.4 ± 4.1 27.0 ± 3.2 26.6 ± 3.9
SBP (mm Hg) 130.6 ± 17.5 130.9 ± 17.7 130.7 ± 17.5
DBP (mm Hg) 70.8 ± 11.1 71.7 ± 11.3 71.1 ± 11.2
Creatinine (mg/dl) 1.1 ± 0.9 1.30 ± 0.4 1.2 ± 0.8
Body surface (m2) 1.6 ± 0.2 1.8 ± 0.1 1.7 ± 0.2
GFR (ml/min/1.73 m2) 61.0 ± 16.9 59.2 ± 16.1 60.4 ± 16.7
CrCl (ml/min) 43.0 ± 11.7 47.5 ± 12.9 45.2 ± 12.2
CrCl-BS (ml/min/1.73 m2) 46.7 ± 11.6 44.5 ± 10.9 45.0 ± 11.4
Total number drugs patient 7.3 ± 3.0 7.2 ± 2.9 7.3 ± 2.9
Drugs with restrictions per patient 4.0 ± 1.9 4.0 ± 2.9 4.0 ± 2.0
Number of DRP per patient 0.7 ± 1.1 0.6 ± 1.1 0.7 ± 1.1
Prevalence of DI (%) 18.3 ± 28.9 15.8 ± 28.4 17.5 ± 28.2
Population with DRP %(n) 35.6(32) 38.2(66) 37.3(98)
Comorbidity %(n)    
 Hypertension 71.7%(124) 67.8%(61) 70.3%(185)
 T2DM 19.7%(34) 24.4%(22) 21.3%(56)
 Dyslipidemia 37.0%(64) 36.7%(33) 36.9%(97)
 Hyper/Hypo Thy 8.1(14) 1.1%(1) 5.7%(15)
 CVD 26.6(46) 31.1%(28) 28.1%(74)
  1. Abbreviations: BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, T2DM Type 2 Diabetes Mellitus, CVD Cardiovascular Disease, THY Thyroidsm, GFR Rate of Glomerular filtration, CrCl Creatinine Clearance, CrCl-BS Creatinine Clearance adjusted to body surface, RI renal impairment, DRP Drug-related problem, DI Dosing inadequacy, Drugs with restrictions (dose adjustment needed in case of renal impairment (RI)) per patient [2022], SD Standard deviation.